Crypto firms donate $21M to Trump-aligned PAC
Crypto companies have poured more than $21 million into a Trump-backed PAC ahead of the 2026 US midterm elections.
Every story in this section, newest first — page 346 of 373.
Crypto companies have poured more than $21 million into a Trump-backed PAC ahead of the 2026 US midterm elections.
Grayscale has declared the first-ever Ethereum staking payout for a US-listed spot crypto ETF.
Chinese financial groups have reclassified RWA tokenisation as illegal, raising the risk of regulatory enforcement.
Strategy has started 2026 with a $116 million Bitcoin buy despite reporting a significant unrealised loss in the previous quarter.
Bank of America has approved adviser-led recommendations of spot Bitcoin ETFs across its US wealth business.
Crypto funds attracted $47.2 billion in 2025, with strong altcoin inflows offsetting a sharp slowdown in Bitcoin demand.
New research cited by an ESG expert challenges long-held claims about Bitcoin mining’s environmental and energy impact.
Drake has been named in a RICO lawsuit accusing him of using crypto casino Stake to hide payments linked to music botting.
Goldman Sachs has upgraded Coinbase on stronger product momentum while cutting its outlook for rival trading platform eToro.
Polymarket has teamed up with Parcl to bring housing price indexes into prediction markets for the first time.
Jollibee Foods Corp. shares saw their largest single-day rally in 18 years on Tuesday after the Philippine fast-food giant announced a transformative plan to spin off its international business and list it on a U.S. stock exchange.
The move is designed to decouple the company’s high-growth global brands from its stable, cash-generative domestic operations, providing investors with "targeted exposure" to two distinct equity stories.
Advanced Micro Devices (NASDAQ:AMD) introduced a sweeping new portfolio of x86 processors at CES 2026, targeting the burgeoning "physical AI" market.
The new Ryzen AI Embedded P100 and X100 series are designed to bring high-performance, low-latency intelligence to automotive cockpits, industrial robotics, and autonomous systems, moving complex decision-making from the cloud to the device itself.
Moderna (NASDAQ:MRNA) officially moved to challenge the multi-billion-dollar seasonal influenza market today, submitting marketing authorization applications for its investigational vaccine, mRNA-1010, to regulators in the U.S., Europe, Canada, and Australia.
UMH Properties (NYSE:UMH) reported a transformative 2025 in its preliminary year-end update, fueled by a record expansion of its rental portfolio and a comprehensive refinancing of its debt stack.
Zenas BioPharma (NASDAQ:ZBIO), a clinical-stage global biopharmaceutical company focused on developing transformative immunology-based therapies for autoimmune diseases, today announced positive topline results from the Phase 3 INDIGO registrational trial evaluating obexelimab in patients with Immunoglobulin G4-Related Disease (IgG4-RD).
Neumora Therapeutics (NASDAQ:NMRA), a clinical-stage biopharmaceutical company focused on developing novel therapies for neuropsychiatric disorders and neurodegenerative diseases, today reported positive topline results from a Phase 1b signal-seeking study evaluating NMRA-511 as a potential treatment for agitation in patients with Alzheimer's disease.
RedHill Biopharma (NASDAQ:RDHL) is positioning its proprietary oral drug, RHB-102 (Bekinda), as a critical solution to the "discontinuation crisis" facing the blockbuster weight-loss drug market.
Gyre Therapeutics (NASDAQ:GYRE) is moving toward a landmark commercial entry in China after securing alignment with the Center for Drug Evaluation (CDE) on a conditional approval pathway for its lead anti-fibrotic candidate, Hydronidone (F351).
GH Research (NASDAQ:GHRS) shares surged in early trading Monday after the U.S. Food and Drug Administration lifted a long-standing clinical hold on its Investigational New Drug (IND) application for GH001.
Mobileye Global (NASDAQ:MBLY) shares jumped more than 7% in premarket trading Monday after the company announced a massive production win with a "top-ten" U.S. automaker.
Lucid Group (NASDAQ:LCID) reported a massive surge in manufacturing activity for 2025, successfully doubling its annual production as it ramps up deliveries of its new Gravity SUV.
The California-based luxury EV maker announced Monday that it produced 18,378 vehicles for the full year, a 104% increase over 2024, narrowly beating analyst estimates of approximately 17,910 units.
Parsons Corporation (NYSE:PSN) announced on Monday that it has been awarded a ten-year, $392 million single-award contract by an undisclosed federal customer.
The win represents "new work" for the Chantilly-based defense technology provider, further solidifying its position in the rapidly expanding market for mobile identity management and biometric security.
CGI (NYSE:GIB) has finalized the acquisition of Comarch Polska SA, a move that significantly expands the Canadian IT firm’s footprint in one of Europe’s fastest-growing digital economies.
Cango (NYSE:CANG) signaled a strong finish to 2025, reporting on Monday that its monthly Bitcoin production rose to 569 BTC in December.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy